NCT00433082

Brief Summary

The metabolic syndrome has been recognized as a proinflammatory state. It has been shown that many different diets such as Mediterranean diet, DASH diet, Foods with low glycemic index and low saturated fat diet, independent of weight loss, may be effective in improving the metabolic syndrome. Our objective was to evaluate the effect of Ramadan fasting on High-sensitive C-reactive protein (hs-CRP) and fibrinogen levels in metabolic syndrome.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Aug 2006

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2006

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2006

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 8, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 9, 2007

Completed
Last Updated

February 9, 2007

Status Verified

February 1, 2007

First QC Date

February 8, 2007

Last Update Submit

February 8, 2007

Conditions

Metabolic Syndrome

Keywords

Metabolic syndrome,Ramadan,Fasting,Inflammatory markers,Iran

Outcome Measures

Primary Outcomes (1)

  • Measuring inflammatory markers in metabolic syndrome

Interventions

Ramadan FastingBEHAVIORAL

Eligibility Criteria

Sexmale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Males with metabolic syndrome

You may not qualify if:

  • Conditions with insulin resistance including;
  • Type 2 diabetes mellitus,
  • Infections,
  • Stresses,
  • Uremia,
  • Acromegaly,
  • Glucocorticoid excess,
  • Hypertension ,
  • Cirrhosis and
  • Any addiction or drug therapy and conditions witch cause changes in hs-CRP and fibrinogen levels including infection, trauma, infarction, inflammatory arthritis, various neoplasm and liver diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Metabolic Syndrome

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Zahra Vahdat Shariatpanahi, MD

    Islamic Free University of Medical Science

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

February 8, 2007

First Posted

February 9, 2007

Study Start

August 1, 2006

Study Completion

November 1, 2006

Last Updated

February 9, 2007

Record last verified: 2007-02